158 related articles for article (PubMed ID: 9665665)
1. Non-acetylcholine displaceable 3[H]epibatidine binding in the rat brain.
Plenge P; Mellerup E
Neurosci Lett; 1998 May; 248(1):65-7. PubMed ID: 9665665
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
Whiteaker P; Jimenez M; McIntosh JM; Collins AC; Marks MJ
Br J Pharmacol; 2000 Oct; 131(4):729-39. PubMed ID: 11030722
[TBL] [Abstract][Full Text] [Related]
3. [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.
Perry DC; Kellar KJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):1030-4. PubMed ID: 7473129
[TBL] [Abstract][Full Text] [Related]
4. Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta.
Han ZY; Zoli M; Cardona A; Bourgeois JP; Changeux JP; Le Novère N
J Comp Neurol; 2003 Jun; 461(1):49-60. PubMed ID: 12722104
[TBL] [Abstract][Full Text] [Related]
5. [3H]Epibatidine binding to bovine adrenal medulla: evidence for alpha3beta4* nicotinic receptors.
Free RB; Bryant DL; McKay SB; Kaser DJ; McKay DB
Neurosci Lett; 2002 Jan; 318(2):98-102. PubMed ID: 11796195
[TBL] [Abstract][Full Text] [Related]
6. Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro.
Deuther-Conrad W; Patt JT; Feuerbach D; Wegner F; Brust P; Steinbach J
Farmaco; 2004 Oct; 59(10):785-92. PubMed ID: 15474055
[TBL] [Abstract][Full Text] [Related]
7. Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine.
Marutle A; Warpman U; Bogdanovic N; Nordberg A
Brain Res; 1998 Aug; 801(1-2):143-9. PubMed ID: 9729344
[TBL] [Abstract][Full Text] [Related]
8. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
Sihver W; Gillberg PG; Nordberg A
Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
[TBL] [Abstract][Full Text] [Related]
9. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
Dávila-García MI; Musachio JL; Kellar KJ
J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
[TBL] [Abstract][Full Text] [Related]
10. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment.
Nguyen HN; Rasmussen BA; Perry DC
J Neurochem; 2004 Jul; 90(1):40-9. PubMed ID: 15198665
[TBL] [Abstract][Full Text] [Related]
11. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.
Marks MJ; Smith KW; Collins AC
J Pharmacol Exp Ther; 1998 Apr; 285(1):377-86. PubMed ID: 9536034
[TBL] [Abstract][Full Text] [Related]
12. Characterization of epibatidine binding to medial habenula: potential role in analgesia.
Plenge P; Mellerup ET; Wörtwein G
J Pharmacol Exp Ther; 2002 Aug; 302(2):759-65. PubMed ID: 12130741
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.
Flores CM; Dávila-García MI; Ulrich YM; Kellar KJ
J Neurochem; 1997 Nov; 69(5):2216-9. PubMed ID: 9349569
[TBL] [Abstract][Full Text] [Related]
14. Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
Houghtling RA; Dávila-García MI; Kellar KJ
Mol Pharmacol; 1995 Aug; 48(2):280-7. PubMed ID: 7651361
[TBL] [Abstract][Full Text] [Related]
15. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
16. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
Nuutinen S; Ahtee L; Tuominen RK
Eur J Pharmacol; 2005 May; 515(1-3):83-9. PubMed ID: 15894304
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
18. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
[TBL] [Abstract][Full Text] [Related]
19. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography.
Perry DC; Xiao Y; Nguyen HN; Musachio JL; Dávila-García MI; Kellar KJ
J Neurochem; 2002 Aug; 82(3):468-81. PubMed ID: 12153472
[TBL] [Abstract][Full Text] [Related]
20. Volatile anesthetics reduce agonist affinity at nicotinic acetylcholine receptors in the brain.
Rada EM; Tharakan EC; Flood P
Anesth Analg; 2003 Jan; 96(1):108-11, table of contents. PubMed ID: 12505934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
